Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?
作者： Nick Beije , Agnes Jager , Stefan Sleijfer
DOI: 10.1016/J.CTRV.2014.12.008
关键词: Primary breast cancer 、 Metastatic breast cancer 、 Cancer cell 、 CA15-3 、 Medicine 、 Blood stream 、 Oncology 、 Enumeration 、 Circulating tumor cell 、 Internal medicine 、 Breast cancer
摘要: Circulating tumor cells (CTCs) are cancer that present in the blood of patients with solid cancers and shed from existing lesions into stream. The enumeration CTCs has long been considered to hold great promise guiding treatment decision-making breast patients. However, guidelines on how use CTC clinical primary metastatic lacking. Here, we set out review most relevant literature date, ultimately come general recommendations regarding cancer.
elsevier.com
sci-hub.se 参考文章(46)
Early Breast Cancer Trialists' Collaborative Group, None, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials The Lancet. ,vol. 365, pp. 1687- 1717 ,(2005) , 10.1016/S0140-6736(05)66544-0
Frank A.W. Coumans, Sjoerd T. Ligthart, Jonathan W. Uhr, Leon W.M.M. Terstappen, Challenges in the enumeration and phenotyping of CTC. Clinical Cancer Research. ,vol. 18, pp. 5711- 5718 ,(2012) , 10.1158/1078-0432.CCR-12-1585
Arjan G. J. Tibbe, M. Craig Miller, Leon W. M. M. Terstappen, Statistical considerations for enumeration of circulating tumor cells Cytometry Part A. ,vol. 71A, pp. 154- 162 ,(2007) , 10.1002/CYTO.A.20369
François-Clément Bidard, Tanja Fehm, Michail Ignatiadis, Jeffrey B. Smerage, Catherine Alix-Panabières, Wolfgang Janni, Carlo Messina, Costanza Paoletti, Volkmar Müller, Daniel F. Hayes, Martine Piccart, Jean-Yves Pierga, Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials Cancer and Metastasis Reviews. ,vol. 32, pp. 179- 188 ,(2013) , 10.1007/S10555-012-9398-0
Bianca Mostert, Jaco Kraan, Anieta M. Sieuwerts, Petra van der Spoel, Joan Bolt-de Vries, Wendy J.C. Prager-van der Smissen, Marcel Smid, Annemieke M. Timmermans, John W.M. Martens, Jan W. Gratama, John A. Foekens, Stefan Sleijfer, CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes Cancer Letters. ,vol. 319, pp. 49- 55 ,(2012) , 10.1016/J.CANLET.2011.12.031
Jaco Kraan, Stefan Sleijfer, Michiel H. Strijbos, Michail Ignatiadis, Dieter Peeters, Jean-Yves Pierga, Francoise Farace, Sabine Riethdorf, Tanja Fehm, Laura Zorzino, Arjan G. J. Tibbe, Marisa Maestro, Rafael Gisbert-Criado, Graeme Denton, Johann S. de Bono, Caroline Dive, John A. Foekens, Jan W. Gratama, External quality assurance of circulating tumor cell enumeration using the CellSearch(®) system: a feasibility study. Cytometry Part B-clinical Cytometry. ,vol. 80, pp. 112- 118 ,(2011) , 10.1002/CYTO.B.20573
François-Clément Bidard, Lisa Belin, Suzette Delaloge, Florence Lerebours, Charlotte Ngo, Fabien Reyal, Séverine Alran, Sylvie Giacchetti, Michel Marty, Ronald Lebofsky, Jean-Yves Pierga, Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study International journal of breast cancer. ,vol. 2013, pp. 130470- 130470 ,(2013) , 10.1155/2013/130470
Jean-Yves Pierga, Thierry Petit, Thierry Delozier, Jean-Marc Ferrero, Mario Campone, Joseph Gligorov, Florence Lerebours, Henri Roché, Thomas Bachelot, Emmanuelle Charafe-Jauffret, Maria Pavlyuk, Sandrine Kraemer, François-Clément Bidard, Patrice Viens, Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study Lancet Oncology. ,vol. 13, pp. 375- 384 ,(2012) , 10.1016/S1470-2045(12)70049-9
F-C Bidard, S Baffert, D Hajage, E Brain, S Armanet, C Simondi, L Mignot, B Asselain, P Tresca, J-Y Pierga, Abstract OT3-4-06: Circulating tumor cells to guide the choice between chemotherapy and hormone therapy as first line treatment for hormone receptors positive metastatic breast cancer patients: the STIC CTC METABREAST trial Cancer Research. ,vol. 72, ,(2012) , 10.1158/0008-5472.SABCS12-OT3-4-06
Min Yu, Aditya Bardia, Nicola Aceto, Francesca Bersani, Marissa W Madden, Maria C Donaldson, Rushil Desai, Huili Zhu, Valentine Comaills, Zongli Zheng, Ben S Wittner, Petar Stojanov, Elena Brachtel, Dennis Sgroi, Ravi Kapur, Toshihiro Shioda, David T Ting, Sridhar Ramaswamy, Gad Getz, A John Iafrate, Cyril Benes, Mehmet Toner, Shyamala Maheswaran, Daniel A Haber, Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility Science. ,vol. 345, pp. 216- 220 ,(2014) , 10.1126/SCIENCE.1253533